Intercept Appoints Andrew Saik as Chief Financial Officer
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Nasdaq, S&P end lower as tech stocks fall
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Rescue work underway after quakes rock Venezuela, 'high casualties' likely
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
Piper Sandler Positive on Intercept Pharmaceuticals (ICPT) Latest Hires
June 9, 2021 11:01 AM EDTPiper Sandler analyst Yasmeen Rahimi reiterated an Overweight rating and $82.00 price target on Intercept Pharmaceuticals (NASDAQ: ICPT) after the company's latest hire - M. Michelle Berrey, M.D., M.P.H., as President of Research & Development and Chief Medical Officer. This follows... More
